N
Patient 1
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VISUMAX LASER KERATOME | LASER, OPHTHALMIC | CARL ZEISS MEDITEC AG (JENA) | HQF | NA | 000000-1345-518 | NA | Y | R |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2017-06-21 | 0 |
Patient 1
Patient 1
THE HEALTH CARE PROFESSIONAL (HCP) REPORTED THAT AN IRREGULAR SURFACE CUTTING OCCURRED ON THE PATIENT'S EYE DURING FLAP CREATION WITH THE VISUMAX. THE HCP MADE A DECISION TO STOP TREATMENT BEFORE LIFTING THE FLAP AND PERFORMING ABLATION OF THE CORNEAL TISSUE. THE PATIENT WAS TREATED WITH ANOTHER VISUMAX IN THE SAME CLINIC. THE PROVIDED PRE- AND POST-OP REFRACTION DATA INDICATE THE PATIENT'S VISUAL ACUITY IMPROVED FROM 1.0 TO 1.2 FOR BOTH EYES. ALL PERTINENT INFORMATION AVAILABLE TO CARL ZEISS MEDITEC HAS BEEN SUBMITTED IN THIS REPORT.